Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07520175Enrolling By Invitation

A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle Glaucoma

Role: lead

NCT07480343Enrolling By Invitation

5-Year Postoperative Outcomes of Patients Who Completed the CREST Study

Role: lead

NCT05506423Enrolling By Invitation

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

Role: lead

NCT06615661Recruiting

A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma

Role: lead

All 4 trials loaded